Medrx Co Ltd (4586)

Currency in JPY
66.0
+1.0(+1.54%)
Closed·
Earnings results expected in 7 days
4586 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
64.068.0
52 wk Range
48.0225.0
Key Statistics
Bid/Ask
66.00 / 67.00
Prev. Close
65
Open
65
Day's Range
64-68
52 wk Range
48-225
Volume
672.7K
Average Volume (3m)
1.66M
1-Year Change
-10.8108%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
4586 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales growth in the current year

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Earnings

Latest Release
May 15, 2026
EPS / Forecast
-4.02 / --
Revenue / Forecast
5M / --
EPS Revisions
Last 90 days

4586 Income Statement

Compare 4586 to Peers and Sector

Metrics to compare
4586
Peers
Sector
Relationship
P/E Ratio
−5.2x−3.8x−0.3x
PEG Ratio
−0.120.020.00
Price/Book
2.1x2.2x2.6x
Price / LTM Sales
29.5x5.2x3.0x
Upside (Analyst Target)
-39.0%56.6%
Fair Value Upside
Unlock14.1%10.2%Unlock

MedRx Co., Ltd, a pharmaceutical formulation development company, provides pharmaceutical drugs based on the transdermal absorption system in Japan. The company develops transdermal medicines based on the ionic liquid transdermal system (ILTS) and the nano-sized colloid transdermal system (NCTS); and microneedle arrays/patch vaccines for the delivery of vaccines and APIs through the skin. Its products also include MRX-5LBT, which has NDA approval in the United States for neuropathic pain; MRX-4TZT, which is in a Phase II trial for spastic paralysis; Alto-101, which is in a Phase II trial for schizophrenia; MRX-9FLT, which is in a Phase I trial for moderate to severe pain; and MRX-6LDT, which is in a drug formulation development stage for chronic pain. MedRx Co., Ltd was incorporated in 2002 and is headquartered in Higashikagawa, Japan.

Employees
21
Market
Japan

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
0.000.00%0.00
Other Institutional Investors
8.60M14.48%550.19M
Public Companies & Retail Investors
50.77M85.52%3.25B
Total
59.37M100.00%3.8B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Long Corridor Asset Management Limited4.78%2,840,000181,760
Rakuten Investment Management, Inc.3.49%2,072,100132,614

FAQ

What Is the Medrx (4586) Stock Price Today?

The Medrx stock price today is 66.0 JPY.

What Stock Exchange Does Medrx Trade On?

Medrx is listed and trades on the Tokyo Stock Exchange.

What Is the Stock Symbol for Medrx?

The stock symbol for Medrx is "4586."

What Is the Medrx Market Cap?

As of today, Medrx market cap is 3.86B JPY.

What Is Medrx's Earnings Per Share (TTM)?

The Medrx EPS (TTM) is -13.2.

When Is the Next Medrx Earnings Date?

Medrx will release its next earnings report on Aug 07, 2026.

From a Technical Analysis Perspective, Is 4586 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Medrx Stock Split?

Medrx has split 0 times.

How Many Employees Does Medrx Have?

Medrx has 21 employees.

What is the current trading status of Medrx (4586)?

As of Jul 31, 2026, Medrx (4586) is trading at a price of 66.0 JPY, with a previous close of 65.0 JPY. The stock has fluctuated within a day range of 64.0 JPY to 68.0 JPY, while its 52-week range spans from 48.0 JPY to 225.0 JPY.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.